“It is more important than ever that providers in the Kingdom have access to the research and diagnostics services relied upon to set global benchmarks for improving healthcare outcomes.
Irvine, CA and Riyadh, Saudi Arabia (PRWEB) May 17, 2016
ResearchDx, the premier Contract Diagnostics Organization (CDO) for the biopharmaceutical industry, and BioSmartSA, a healthcare consultancy based in Saudi Arabia, have formed a partnership to bring their expertise in navigating the design and management of diagnostic services to healthcare providers in the Kingdom of Saudi Arabia (KSA).
The partnership addresses the specific needs of the KSA healthcare sector—recognized throughout the Middle East as a leader in the use of accreditation to improve healthcare—in the preparatory phase for new accreditation standards set to take effect in 2020. The firms will collaborate to provide market-tailored services in clinical research, clinical trial support, laboratory regulatory services, diagnostic development, kit and reagent manufacturing, and early-stage support. ResearchDx will administer services, while BioSmartSA will lend market expertise in Saudi Arabia and throughout the Middle East.
ResearchDx, founded in 2008 by Dr. Philip D. Cotter and Dr. Mathew W. Moore, provides comprehensive consulting for the diagnostics development process— from initial assay concept and discovery through clinical research and regulatory approval. As a Contract Diagnostics Organization (CDO), ResearchDx offers clients an integrated outsource solution to guide the rapid development, manufacture and commercialization of diagnostic assays. ResearchDx delivers simplicity as a one-stop-shop for the coordination of essential partner services such as international regulators, Contract Research Organizations (CROs), clinical services and manufacturers.
BioSmartSA, founded in 2016 by Saudi Arabia’s top consultant scientists, provides quality improvement programs, accreditation and service establishment within best practice guidelines to clinical laboratories, hospitals and blood banks. BioSmartSA performs comprehensive compliance and standards assessments of partner organizations to design and execute custom work plans that reach all quality targets.
This alliance comes as healthcare providers in the KSA enter a critical phase of preparation for the 3rd Edition of National Standards for Hospitals. All providers must meet the new standards by 2020 in order to receive accreditation from the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI). The new guidelines arrive at a critical juncture for Saudi Arabian healthcare; spending is set to reach SR174 billion by 2017 amidst unprecedented demand from a growing, aging populace. The new guidelines continue the established CBAHI practice of using accreditation to promote the continuous improvements that maintain costs and improve patient outcomes. ResearchDx and BioSmartSA, through their alliance, offer KSA healthcare providers a knowledge base pivotal to navigate the new standards.
“Everyone at ResearchDx recognizes the value common standards bring patients, and the Saudi Ministry of Health has been at the forefront of using common standards to drive improvements in care,” said Philip D. Cotter, Principal, ResearchDx. “It is more important than ever that providers in the Kingdom have access to the research and diagnostics services relied upon to set global benchmarks for improving healthcare outcomes. That is why we are so excited to partner with BioSmartSA and offer our combined expertise in the Kingdom.”
“Our scientists here at BioSmartSA can collectively count scores of successful accreditation processes as experience, and have been instrumental to the advances the KSA healthcare sector made over the last two decades,” said the BioSmartSA chief clinical scientist. “Our partnership with ResearchDx realizes a joint goal of harmonizing the clinical laboratory practice of thorough standardization and accreditation while delivering exceptional service throughout the accreditation journey."
ResearchDx was founded to equip biopharmaceutical companies with the knowledge and expertise to develop and manufacture the next generation of companion diagnostic products. As the preeminent Companion Diagnostics Organization, ResearchDx offers management services for every stage of the diagnostic development process—from initial assay concept and discovery through clinical research and international regulatory approval. Learn how ResearchDx personalizes medicine at http://researchdx.com/about-us/.
BioSmartSA offers specialized service and quality consultation to clinical laboratories in the public and private sectors. With dozens of successful accreditation processes as experience, BioSmartSA scientists provide service consultations tailored to address client needs in the preparation of scientific and operational proposals for new service and benchmarking, quality and accreditation evaluation, and preparation for accreditation inspections.